D. Rjosk

812 total citations
22 papers, 630 citations indexed

About

D. Rjosk is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, D. Rjosk has authored 22 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Cancer Research and 7 papers in Pathology and Forensic Medicine. Recurrent topics in D. Rjosk's work include Breast Cancer Treatment Studies (9 papers), Cancer Cells and Metastasis (7 papers) and Breast Lesions and Carcinomas (5 papers). D. Rjosk is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Cells and Metastasis (7 papers) and Breast Lesions and Carcinomas (5 papers). D. Rjosk collaborates with scholars based in Germany and Austria. D. Rjosk's co-authors include Wolfgang Janni, Christian Schindlbeck, Stephan Braun, F. Hepp, B. Strobl, Harald Sommer, Christina Kentenich, Brigitte Rack, Klaus Pantel and Th. Dimpfl and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. Rjosk

21 papers receiving 611 citations

Peers

D. Rjosk
E. Merkle Germany
Adrian Murray Brunt United Kingdom
Gregory M. Heestand United States
Anja Welt Germany
Sheryl L. Parker United States
V. Harvey New Zealand
D. Rjosk
Citations per year, relative to D. Rjosk D. Rjosk (= 1×) peers Véronique Mari

Countries citing papers authored by D. Rjosk

Since Specialization
Citations

This map shows the geographic impact of D. Rjosk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Rjosk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Rjosk more than expected).

Fields of papers citing papers by D. Rjosk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Rjosk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Rjosk. The network helps show where D. Rjosk may publish in the future.

Co-authorship network of co-authors of D. Rjosk

This figure shows the co-authorship network connecting the top 25 collaborators of D. Rjosk. A scholar is included among the top collaborators of D. Rjosk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Rjosk. D. Rjosk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schindlbeck, Christian, Peer Hantschmann, D. Rjosk, et al.. (2007). Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow. International Journal of Gynecological Cancer. 17(5). 1047–1055. 30 indexed citations
2.
Schindlbeck, Christian, W Janni, Brigitte Rack, et al.. (2005). Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?. Journal of Cancer Research and Clinical Oncology. 131(8). 539–546. 13 indexed citations
3.
Janni, Wolfgang, Brigitte Rack, Christian Schindlbeck, et al.. (2005). The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer. 103(5). 884–891. 124 indexed citations
4.
Strobl, B., et al.. (2004). Whole body hyperthermia combined with carboplatin/ paclitaxel in patients with ovarian carcinoma –Phase-II-study. Journal of Clinical Oncology. 22(14_suppl). 5128–5128. 2 indexed citations
5.
Rack, Brigitte, W Janni, A. Schoberth, et al.. (2004). Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer. Journal of Clinical Oncology. 22(14_suppl). 9515–9515. 13 indexed citations
6.
Janni, Wolfgang, Brigitte Rack, Harald Sommer, et al.. (2003). Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. Journal of Cancer Research and Clinical Oncology. 129(9). 503–510. 20 indexed citations
7.
Janni, Wolfgang, F. Hepp, B. Strobl, et al.. (2003). Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer. 97(2). 405–411. 21 indexed citations
8.
Janni, W, B. Strobl, D. Rjosk, et al.. (2003). 426 Intramammary tumor location (ITL) does not influence prognosis, but the prevalence of axillary lymph node metastases. European Journal of Cancer Supplements. 1(5). S129–S130.
9.
10.
Janni, W, et al.. (2003). 372 Average tumor size and overall survival of patients with primary diagnosis of breast cancer influenced by a more frequent use of mammography. European Journal of Cancer Supplements. 1(5). S114–S115. 1 indexed citations
11.
Janni, W, et al.. (2002). Der Einfluss des Hämoglobinwertes auf die hämatogene Tumorzelldisseminierung zum Zeitpunkt der Primärdiagnose des Mammakarzinoms. DMW - Deutsche Medizinische Wochenschrift. 127(3). 71–77. 2 indexed citations
12.
13.
Janni, W, Th. Dimpfl, D. Rjosk, et al.. (2001). Matched pair analysis of survival after chest-wall recurrence compared to mammary recurrence: a long-term follow-up. Journal of Cancer Research and Clinical Oncology. 127(7). 455–462. 11 indexed citations
14.
Janni, Wolfgang, D. Rjosk, B. Strobl, et al.. (2001). Chemotherapieassoziierte Myelosuppression in der gynäkologischen Onkologie. Gyn�kologisch-geburtshilfliche Rundschau. 41(3). 166–173. 5 indexed citations
15.
Rjosk, D., Th. Dimpfl, B. Strobl, et al.. (2001). Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer?Long-Term Follow-Up of a Matched-Pair Analysis. Annals of Surgical Oncology. 8(6). 542–548. 96 indexed citations
16.
Braun, Stephan, Wolfgang Janni, Christina Kentenich, et al.. (2001). Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy. Journal of Clinical Oncology. 19(5). 1468–1475. 117 indexed citations
17.
Janni, W, Kristin Härtl, B. Strobl, et al.. (2001). Quality of life influenced by primary surgical treatment for stage I–III breast cancer - long-term follow-up of a matched-pair analysis. European Journal of Cancer. 37. S264–S264. 26 indexed citations
18.
Janni, Wolfgang, F. Hepp, Christina Kentenich, et al.. (2000). Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma. Cancer. 88(10). 2252–2259. 56 indexed citations
19.
Janni, Wolfgang, T. Dimpfl, Stephan Braun, et al.. (2000). Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival. International Journal of Radiation Oncology*Biology*Physics. 48(4). 967–975. 18 indexed citations
20.
Janni, Wolfgang, D. Rjosk, & Stephan Braun. (2000). Clinical Relevance of Occult Metastatic Cells in the Bone Marrow of Patients with Different Stages of Breast Cancer. Clinical Breast Cancer. 1(3). 217–225. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026